Acalabrutinib side effects

Acalabrutinib (Acalabrutinib) is a BTK (brutinib) inhibitor used to treat B Cellular malignancies, such as chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), have a range of possible side effects. The following is a detailed introduction to the possible side effects of acotinib:

Common side effects:

1.Hypertension: Hypertension may occur during acotinib treatment. Patients' blood pressure needs to be monitored regularly before, during, and after treatment, and appropriate medications or lifestyle adjustments may be needed to control high blood pressure.

2.Headache: Patients may experience headache discomfort while taking acotinib. This side effect is usually mild, but if symptoms are severe or persist for a long time, patients should inform their doctor promptly.

3.Diarrhea: Acotinib may cause mild to moderate diarrhea. Patients should maintain adequate fluid intake during treatment to prevent or reduce the discomfort of diarrhea.

4.Muscle pain: Some patients may experience muscle or joint pain while taking acotinib. This is usually mild, but patients should report any discomfort to their doctor.

5.Fatigue: During acotinib treatment, patients may feel fatigue or lack of energy. Rest and maintaining a good lifestyle can help relieve this symptom.

6.Bleeding tendency: Some patients may experience symptoms such as easy congestion, congestion and ecchymosis when taking acotinib. Serious bleeding is a relatively rare but cause for concern side effect.

Serious side effects:

1.Heart problems: A very small number of patients may develop heart problems, such as arrhythmia, while taking acotinib. Doctors usually perform a heart evaluation before treatment begins and monitor it regularly during treatment.

2.High cholesterol: Acotinib may cause high cholesterol levels. Doctors may recommend that patients undergo regular cholesterol testing and take necessary steps to manage high cholesterol.

3.Liver function abnormalities: Some patients may experience liver function abnormalities, including elevated liver enzyme levels, while taking acotinib. Regular monitoring of liver function is an important measure during treatment.

4.Infection risk: Because acotinib inhibits B cells in the immune system, patients may be more susceptible to infections. During treatment, doctors may monitor the patient's immune status and take preventive measures.

5.Risk of other malignancies: In some cases, the use of acotinib may be associated with an increased risk of other malignancies.

Notes:

1.Pregnant and lactating women: Pregnant women should avoid using acotinib, while lactating women need to stop breastfeeding during treatment. Female patients need to take effective contraceptive measures during treatment.

2.Elderly patients: For elderly patients, doctors may adjust the dose based on their physiological status and other related factors.

3.Hepatic insufficiency: If the patient has hepatic insufficiency, the dose of acotinib may need to be adjusted.

Patients should pay close attention to the occurrence of any side effects during medication and report them to their doctor in a timely manner. Doctors will adjust the treatment plan according to the patient's specific situation to minimize the impact of side effects while ensuring efficacy. Any discomfort or concerns should be discussed in detail with your doctor. Overall, acotinib has been shown to be relatively well tolerated in clinical trials and practical applications, but patients need to receive treatment under physician supervision to ensure safe and effective use.

Acotinib has been launched in China, but it has not yet been included in medical insurance. Since it has just been launched, it is still difficult for patients to purchase it domestically. They need to purchase acotinib through overseas channels. The cheaper ones abroad are mainly generic drugs, mainly Bangladeshi generic drugs. The price is around 6,000 to 7,000, and the ingredients of original drugs and generic drugs are basically the same.